Peritoneal inclusion cysts treated with a levonorgestrel-releasing intrauterine system: A case report

• Published in: Case reports in women's health Vol. 22; p. e00113
• Main Authors: Tamai, Hanako, Kinugasa, Masato, Nishio, Miho, Miyake, Mayu
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01-04-2019; Elsevier
• Subjects: Levonorgestrel-releasing intrauterine system; Peritoneal inclusion cysts; OC(s); PICs; Levonorgestrel-releasing intrauterine system; Peritoneal inclusion cysts; LNG-IUS; GnRHa; OC(s), oral contraceptive(s); GnRHa, gonadotropin releasing hormone agonist; PICs, peritoneal inclusion cysts; LNG-IUS, levonorgestrel-releasing intrauterine system
• ISSN: 2214-9112; 2214-9112
• DOI: 10.1016/j.crwh.2019.e00113

Patients with peritoneal inclusion cysts (PICs) often suffer from progressive abdominal or pelvic pain. There is no established treatment. We present the case of a 42-year-old woman with PICs complaining of progressive abdominal pain and fullness who was initially treated with drainage and gonadotropin releasing hormone agonist (GnRHa). Despite the treatment, her symptoms worsened approximately one year later. She was again treated with drainage and GnRHa, and subsequently a levonorgestrel-releasing intrauterine system (LNG-IUS) was placed in her intrauterine cavity. Thereafter, her condition stabilized and no complications were reported. The LNG-IUS may be an effective management option for patients with PICs.
•Patients with peritoneal inclusion cysts often suffer from progressive pelvic pain.•Hormonal treatment stabilizes the size of the cyst and controls symptoms.•In this case, a levonorgestrel-releasing intrauterine system was effective.•This treatment has fewer adverse effects and fewer contraindications, as the drug is locally administered.•The treatment is more cost-effective than other interventions and patient compliance is greater.